Trial · NCT05584605
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 18 of 18
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Brain imaging - cerebrovascular reactivity (CVR) by BOLD-fMRI | post-intervention (12 weeks) | Functional brain tissue perfusion and tissue at risk based on cerebrovascular reactivity by blood oxygenation-level dependent functional magnetic resonance imaging (BOLD-fMRI), measured as the percentage BOLD signal change /mmHg CO2. |
| Secondary | Brain imaging - intravoxel incoherent motion (IVIM) | post-intervention (12 weeks) | Functionality of brain microvasculature by measuring diffusion and perfusion components of tissue based on intravoxel incoherent motion |
| Secondary | Brain imaging - NOVA-qMRI | post-intervention (12 weeks) | Blood flow velocity based on non-invasive optimal vessel analysis quantitative magnetic resonance imaging |
| Secondary | Brain imaging - Lesion volume | post-intervention (12 weeks) | based on 3D T1 weighted imaging, 3D Fluid-Attenuated Inversion Recovery (FLAIR), Diffusion-Eighted Imaging (DWI) |
| Secondary | Brain imaging - Collateral status | post-intervention (12 weeks) | Collateral status based on 3D time of flight angiography (TOF) |
| Secondary | Exercise stress testing | post-intervention (12 weeks) | Cycle ergometer testing with spirometry |
| Secondary | Six-Minute Walk Test (6MWT) | post-intervention (12 weeks) + follow-up (+3 months) | Functional walking capacity in meters |
| Secondary | Ten-Meter Walk Test (10MWT) | post-intervention (12 weeks) + follow-up (+3 months) | Walking speed in m/s |
| Secondary | Fugl-Meyer Assessment of the Lower Extremity (FMMA-LE) | post-intervention (12 weeks) + follow-up (+3 months) | Stroke-specific motor impairment index to assess lower limb motor function with a total score ranging from 0 to 34 and higher scores indicating better performance. |
| Secondary | Motricity Index of the Lower Extremity (MI-LE) | post-intervention (12 weeks) + follow-up (+3 months) | Muscle strength assessment of three major muscle groups of the lower extremity with a total score ranging from 0 to 100 and higher scores indicating better performance. |
| Secondary | 5-Chair-Rise-Test | post-intervention (12 weeks) + follow-up (+3 months) | Functional muscle strength, measured in seconds to complete the task. |
| Secondary | International Physical Activity Questionnaire (IPAQ) | post-intervention (12 weeks) + follow-up (+3 months) | self-reported physical activity |
| Secondary | Montreal Cognitive Assessment (MoCA) | post-intervention (12 weeks) + follow-up (+3 months) | Screening assessment of cognitive functions with a maximum score of 30 points. |
| Secondary | Word list learning | post-intervention (12 weeks) + follow-up (+3 months) | Assessment of memory function |
| Secondary | Digit Span Test / Corsi block | post-intervention (12 weeks) + follow-up (+3 months) | Assessment verbal and nonverbal working memory |
| Secondary | Stroop test | post-intervention (12 weeks) + follow-up (+3 months) | Assessment of executive function and inhibition |
| Secondary | European Quality of Life 5 Dimensions 5 Level (5Q-5D-5L) | post-intervention (12 weeks) + follow-up (+3 months) | Quality of life questionnaire that assesses 5 dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) on a 5-level scale ranging from 1 - no, 2 - slight, 3 - moderate, 4 - severe to 5 - extreme problems or unstable to. |
| Other | Concomitant medications | post-intervention (12 weeks) + follow-up (+3 months) | covariate |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05584605/registered